updates to adjuvant treatment for melanoma from combi-ad
Published 2 years ago • 14 plays • Length 6:09Download video MP4
Download video MP3
Similar videos
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
4:12
adjuvant therapy in melanoma: combi-ad trial
-
5:59
optimizing the approach to adjuvant therapy for resected melanoma
-
5:36
key takeaways from esmo - updates in targeted therapy for melanoma
-
3:37
adjuvant therapy for resected stage iii melanoma
-
9:40
melanoma updates adjuvant treatment options for melanoma
-
4:14
adjuvant therapy for melanoma: novel treatment options
-
10:47
asco: pembrolizumab for adjuvant treatment of high-risk stage iii melanoma
-
17:55
adjuvant therapy for melanoma - amaria
-
1:06:02
sysf webinar: treatment options for melanoma patients in the adjuvant setting
-
8:48
combi-ad: dual-targeted therapy for stage 3 melanoma
-
2:47
adjuvant therapy for high-risk melanoma
-
2:55
adjuvant therapy for melanoma - 2022 program: melanoma video library
-
11:14
melanoma in the covid-19 era: adjuvant therapy
-
1:30
adjuvant therapy for high-risk melanoma
-
7:39
adjuvant nivolumab versus ipilimumab for resected stage iii/iv melanoma
-
27:18
adjuvant and neoadjuvant dilemmas
-
5:01
adjuvant therapy update
-
5:22
adjuvant therapy in stage 3 and 4 melanoma - 2022 program: melanoma video library